Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 3, 2026ARKGS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +2.5% | −12.8% | +20.1% | +70.9% | +59.0% | +122.6% | −34.1% | +166.0% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $2.2B
- Expense ratio
- 0.75%
- Distribution yield
- 0.0%
- NAV
- $48.33
- Volume
- 4.8M
- Avg. volume 30D
- 5.7M
- High today
- $50.80
- Low today
- $48.79
- Previous close
- $48.29
- 52-week high
- $58.83
- 52-week low
- $24.60
- Our risk indicator
- 4/5
ARKG in One Breath
ARKG Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in ARKG
5Y$10,000 in ARKG became
$6,586
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
ARKG’s Top Holdings
TodayTEMTempus Ai -9.8%TXG7.5%TWST7.4%CRSP5.5%GH5.1%ABSI5.1%NTRA4.7%LLY4.6%CDNA4.5%ILMN4.3%BEAM3.8%VCYT3.8%SDGR2.9%RXRX2.9%NRIX2.9%ADPT2.3%CMPS2.0%NTLA1.9%IONS1.8%PRME1.7%WGS1.7%ALMROther
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - Application
ARK ARKG · 10 holdings · tile size = share of the fund · as of Nov 3, 2026
What ARKG Holds
TodayBiotechnology49.6%
TXG 7.5 · TWST 7.4 · CRSP 5.5 · ABSI 5.1 · BEAM 3.8 · RXRX 2.9 · NRIX 2.9
Medical - Diagnostics & Research25.7%
GH 5.1 · NTRA 4.7 · CDNA 4.5 · ILMN 4.3 · VCYT 3.8 · WGS 1.7 · FRNM
Medical - Healthcare Information Services9.8%
TEM 9.8
Drug Manufacturers - General4.6%
LLY 4.6
Software - Application3.8%
SDGR 2.9 · IAM
Medical - Devices3.8%
BFLY 1.5 · PACB 1.3 · CERS
Medical - Specialties1.0%
MASS
ARK ARKG · share of the fund by industry · as of Nov 3, 2026
Tempus’ Share of ARKG
Today9.8%
$98 of every $1,000 in ARKG is Tempus
Tempus held by ARKG
$219M
ARK ARKG · each square = $10 of $1,000 · as of Nov 3, 2026
ARKG’s Share of Health Care ETFs
Today2.0%
of the $109B in 39 Health care ETFs
$2.2B2.0%
$49.1B45.0%
$19.1B17.5%
$38.6B35.4%
Health care ETF AUM · Nov 4, 2026
ARKG Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside ARKG
10 holdings · as of Nov 3, 2026ARKG
ARK Genomic Revolution ETF
TodayBiotechnology49.6%TXG7.5%TWST7.4%CRSP5.5%ABSI5.1%BEAM3.8%RXRX2.9%NRIX2.9%ADPT2.3%CMPS2.0%NTLAIONSPRMEALMRARCT2 moreMedical - Diagnostics25.7%GH5.1%NTRA4.7%CDNA4.5%ILMN4.3%VCYT3.8%WGSFRNMPSNLMedical - Healthcare Information Services9.8%TEM9.8%Drug Manufacturers - General4.6%LLY4.6%Software - Application3.8%SDGR2.9%IAMMedical - Devices3.8%BFLYPACBMASSSCTXQSI
Biotechnology49.6%TXG7.5%TWST7.4%CRSP5.5%ABSI5.1%BEAMRXRX10 more holdings17.3% of the fundMedical - Diagnostics25.7%GH5.1%NTRA4.7%CDNA4.5%ILMN4.3%VCYT3.8%WGSMedical - Healthcare Information Services9.8%TEM9.8%Drug Manufacturers - General4.6%LLYSoftware - Application3.8%SDGRMedical - Devices3.8%BFLYPACBCERSMASSSCTXQSI
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TEM | Tempus AI - | 9.85% |
| 2 | TXG | 10X Genomics - | 7.52% |
| 3 | TWST | Twist Bioscience | 7.42% |
| 4 | CRSP | Crispr Therapeutics AG | 5.48% |
| 5 | GH | Guardant Health | 5.13% |
| 6 | ABSI | Absci | 5.08% |
| 7 | NTRA | Natera | 4.67% |
| 8 | LLY | ELI Lilly & | 4.59% |
| 9 | CDNA | Caredx | 4.50% |
| 10 | ILMN | Illumina | 4.26% |
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - ApplicationMedical - DevicesMedical - SpecialtiesOther
ARK ARKG · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 84.6%
How It Compares
ARKG
ARK Genomic Revolution ETF’s Peers
1YHealth care peers · Past-year and ytd returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put ARKG head to head with XLV →XLV vs ARKG
YTDYear to date
ARKG wins+50.5 pts
Past year
ARKG wins+29.3 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV22.1× more
2–2level
SPDR XLV and ARK ARKG · year-to-date · as of Nov 4, 2026 · AUM not scored
ARKG vs VOO
1YARKG · ARK Genomic Revolution
+59.0%
VOO · S&P 500
+11.9%
Gap
47.2 pts
ARK ARKG and Vanguard VOO · 1Y total return · as of Nov 4, 2026
ARKG vs Its Peer Average
YTDARKGAvsBPeer average
1D+2.5%+0.6%
1M−12.8%+4.0%
3M+20.1%+6.1%
YTD+70.9%+21.0%
1Y+59.0%+29.0%
3Y+122.6%+81.2%
5Y−34.1%+28.9%
5–2ARKG wins
38 Health care peers · each row scaled to its leader
The Details
ARKG
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y45.81%
Deepest drop · 1Y−27.5%
Lowest point · 5Y−73.7%
52-week range
$49.51
$24.60−15.8% from the high$58.83
ARK ARKG · past-year price moves · as of Nov 4, 2026
ARKG
Fund Facts
Today2014launched Oct 31
Tracks[…]
Exchange · CUSIPCBOE · 00214Q302
StructureETF
Leverage1x
Cost on $10,000$75 a year
Go deeper
ARK ARKG · fund facts · as of Nov 4, 2026
ARKG
Payouts by Year
5Y$0.38per share, Dec 2021
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 29 · Dec 31, 2021
5 payouts added up$3.02 a share
ARK ARKG · distributions by ex-date · 2017–2021
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-07-31 ↗SEC reported portfolio · 2026-04-30 ↗SEC reported portfolio · 2026-01-30 ↗SEC reported portfolio · 2025-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-07-31 ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-07-31 ↗SEC reported portfolio · 2024-04-30 ↗SEC reported portfolio · 2024-01-31 ↗SEC reported portfolio · 2023-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-07-31 ↗SEC reported portfolio · 2023-04-28 ↗SEC reported portfolio · 2023-01-31 ↗SEC reported portfolio · 2022-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-07-29 ↗SEC reported portfolio · 2022-04-29 ↗SEC reported portfolio · 2022-01-31 ↗SEC reported portfolio · 2021-10-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-07-30 ↗SEC reported portfolio · 2021-04-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-01-29 ↗SEC reported portfolio · 2020-10-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-07-31 ↗SEC reported portfolio · 2020-04-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$48.33
Premium / discount[…]
Median spread · 30D[…]
Volume today4.8M
Average volume · 30D5.7M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.75%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$75.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 29, 2021 | Dec 31, 2021 | $0.38 |
| Dec 29, 2020 | Dec 31, 2020 | $0.79 |
| Dec 27, 2019 | Dec 31, 2019 | $1.05 |
| Dec 27, 2018 | Dec 31, 2018 | $0.47 |
| Dec 27, 2017 | Dec 29, 2017 | $0.33 |
Issuer contentFrom ARKHear the strategy from the people behind ARKG.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →